Remove 2023 Remove Animal Testing Remove Clinical Pharmacology Remove Research
article thumbnail

Drug repurposing: The benefits, risks and what we learned from Covid-19

Drug Discovery World

Diana Spencer summarises the key messages from the ‘Drug Repurposing: Challenges and Opportunities’ Symposium held at the 19th World Congress of Basic & Clinical Pharmacology (WCP) 2023. She urged that new methodologies are needed to reduce human and animal testing to establish safety and efficacy.

article thumbnail

Analysis Life Sciences Thank You The 53 regulations that FDA is currently working on

Agency IQ

For example, the FDA does not have a proposed rule listed that would change how it regulates animal testing requirements following the passage of the FDA Modernization Act 2.0 It’s also interesting to see what isn’t on this list. provisions of the Food and Drug Omnibus Reform Act (FDORA) in 2022. and the E.C.